'
The combination of curcumin and 5-fluorouracil in cancer therapy' 의 참고문헌
Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a secondary analysis of a randomized phase 3 clinical trial
The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-<TEX>${\kappa}B$</TEX> signaling cascade in MDR-induced stem like cancer-initiating cells
The effect of focal adhesion kinase gene silencing on 5-fluorouracil chemosensitivity involves an Akt/NF-kappaB signaling pathway in colorectal carcinomas
Survival benefit and safety of the combinations of FOLFOXIRI <TEX>${\pm}$</TEX> bevacizumab versus the combinations of FOLFIRI <TEX>${\pm}$</TEX> bevacizumab as first-line treatment for unresectable metastatic colorectal cancer: a meta-analysis
Role and mechanism research on reversal of 5-fluorouracil resistance by epigallocatechin gallate in gastric cancer drug-resistance cells lines SGC-7901/5-FU
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
Randomized phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106)
Phosphatase and tensin homolog (PTEN) represses colon cancer progression through inhibiting paxillin transcription via PI3K/AKT/NF-<TEX>${\kappa}B$</TEX> pathway
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: eastern Cooperative Oncology Group Trial E2297
Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity
Inhibition of NF-<TEX>${\kappa}B$</TEX> translocation by curcumin analogs induces G0/G1 arrest and downregulates thymidylate synthase in colorectal cancer
In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N, O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies
Hedyotis diffusa Willd overcomes 5-fluorouracil resistance in human colorectal cancer HCT-8/5-FU cells by down-regulating the expression of P-glycoprotein and ATP-binding casette subfamily G member 2
Efficacy and safety of gemcitabine-fluorouracil combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomized controlled trials
Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-<TEX>${\kappa}B$</TEX> as well as induction of apoptosis and G2/M arrest
Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs
Curcumin suppresses doxorubicin-induced epithelial-mesenchymal transition via the inhibition of TGF-<TEX>${\beta}$</TEX> and PI3K/AKT signaling pathways in triple-negative breast cancer cells
Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-<TEX>${\kappa}B$</TEX> signaling pathway in vitro and in vivo
Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-<TEX>${\kappa}B$</TEX> signalling pathway
Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer
Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1
Curcumin inhibits cell proliferation and promotes apoptosis in human osteoclastoma cell through MMP-9, NF-<TEX>${\kappa}B$</TEX> and JNK signaling pathways
Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy
Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-<TEX>${\kappa}B$</TEX> and Src protein kinase signaling pathways
Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial
Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors
Apoptotic death in curcumin-treated NPC-TW 076 human nasopharyngeal carcinoma cells is mediated through the ROS, mitochondrial depolarization and caspase-3-dependent signaling responses
Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase 3 multicentre randomised controlled trial
